Greater Cannabis Company (GCAN) Asset Utilization Ratio (2018 - 2021)
Greater Cannabis Company's (GCAN) quarterly Asset Utilization Ratio came in at 0.03 in Q4 2021, down 89.24% year-on-year from 0.26 in Q4 2020, and up 21.12% quarter-over-quarter from 0.02 in Q3 2021.
Greater Cannabis Company (GCAN) Asset Utilization Ratio (2018 - 2021) Analysis & Trends
Greater Cannabis Company's Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 0.03 for Q4 2021.
- On a quarterly basis, Asset Utilization Ratio fell 89.24% year-over-year to 0.03 in Q4 2021; TTM through Dec 2021 was 0.03, a 89.24% decrease from a year earlier, with the FY2021 full-year figure at 0.04, down 89.32% from the prior year.
- Asset Utilization Ratio climbed to 0.03 in Q4 2021 per GCAN's latest filing, from 0.02 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.1 in Q4 2018 and bottomed at 0.02 in Q3 2021.
- The 4-year median for Asset Utilization Ratio is 0.26 (2020), against an average of 0.45.
- Across the five-year window, Asset Utilization Ratio fell 1.12% in 2019 and sank 89.55% in 2021, its largest moves.
- Year by year, Asset Utilization Ratio stood at 1.1 in 2018, then slipped by 1.12% to 1.09 in 2019, then sank by 76.03% to 0.26 in 2020, then slumped by 89.24% to 0.03 in 2021.
- Per Business Quant, the three latest GCAN Asset Utilization Ratio figures stand at 0.03 (Q4 2021), 0.02 (Q3 2021), and 0.13 (Q2 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.43 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.62 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.46 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.43 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.39 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.65 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.37 |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 0.03 |
| Sep 30, 2021 | 0.02 |
| Jun 30, 2021 | 0.13 |
| Dec 31, 2020 | 0.26 |
| Sep 30, 2020 | 0.22 |
| Jun 30, 2020 | 0.46 |
| Dec 31, 2019 | 1.09 |
| Sep 30, 2019 | 0.73 |
| Dec 31, 2018 | 1.10 |